MD Anderson and Hummingbird Bioscience Announce Strategic Research Collaboration to Advance Innovative Immunotherapies
July 13, 2021
July 13, 2021
HOUSTON, Texas, July 13 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release on July 12, 2021:
* * *
Multi-year collaboration will investigate and evaluate Hummingbird's HMBD-002 VISTA antagonist antibody
* * *
The University of Texas MD Anderson Cancer Center and Hummingbird Bioscience today announced the launch of a multi-year strategic research collaboration to investigate and evaluate H . . .
* * *
Multi-year collaboration will investigate and evaluate Hummingbird's HMBD-002 VISTA antagonist antibody
* * *
The University of Texas MD Anderson Cancer Center and Hummingbird Bioscience today announced the launch of a multi-year strategic research collaboration to investigate and evaluate H . . .